IAA
FOLD

Ironsides Asset Advisors’s Amicus Therapeutics FOLD Stock Holding History

Ironsides Asset Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,220
Closed -$184K – 79
2020
Q2 		$184K Buy
12,220
+100
+0.8% +$1.22K 0.06% 74
2020
Q1 		$112K Buy
+12,120
New +$115K 0.07% 64

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ironsides Asset Advisors's FOLD Position: Q3 2020 in Review

Ironsides Asset Advisors sold out of Amicus Therapeutics (FOLD) in Q3 2020, closing a stake of 12,220 shares — an estimated $184K sold.

Ironsides Asset Advisors first reported a position in FOLD in Q1 2020 and held it in 2 quarters. The position peaked at $184K in Q2 2020. 251 funds tracked by Wall St. Rank hold FOLD as of Q3 2020.

  • Ironsides Asset Advisors reported no remaining Amicus Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Ironsides Asset Advisors sold 12,220 Amicus Therapeutics shares in Q3 2020, an estimated $184K.
  • Ironsides Asset Advisors first reported a position in Amicus Therapeutics in Q1 2020 and held it in 2 quarters.
  • Ironsides Asset Advisors's Amicus Therapeutics position peaked at $184K in Q2 2020.
  • 251 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2020.

Based on Ironsides Asset Advisors's 13F filing for Q3 2020, filed 10 Nov 2020.